NCT02486562

Brief Summary

iConquerMS™ is a research initiative developed by and for people with multiple sclerosis (MS) to contribute their health data and ideas to advance and accelerate research into MS. iConquerMS welcomes adults with MS and others interested in advancing MS research, children and teens with MS and their family members (via iConquerMS Kids \& Teens) and MS caregivers (via iConquerMS Caregivers) to participate.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20,000

participants targeted

Target at P75+ for all trials

Timeline
127mo left

Started Nov 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress53%
Nov 2014Oct 2036

Study Start

First participant enrolled

November 1, 2014

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

June 25, 2015

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 1, 2015

Completed
15.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2030

Expected
6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2036

Last Updated

February 18, 2025

Status Verified

February 1, 2025

Enrollment Period

15.9 years

First QC Date

June 25, 2015

Last Update Submit

February 14, 2025

Conditions

Multiple Sclerosis

Keywords

Multiple SclerosisMS

Outcome Measures

Primary Outcomes (1)

  • Number of people with multiple sclerosis who experience health-related quality-of-life changes

    1 year

Study Arms (1)

People diagnosed with Multiple Sclerosis

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Primary cohort is people with multiple sclerosis.

You may qualify if:

  • years of age or older at the time of informed consent or under 21 with parental consent and participant assent.

You may not qualify if:

  • Unwilling or unable to provide informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Accelerated Cure Project

Waltham, Massachusetts, 02451, United States

RECRUITING

MeSH Terms

Conditions

Multiple Sclerosis

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Central Study Contacts

Sara Loud, MSEE, MBA

CONTACT

781-487-0032sloud@acceleratedcure.org

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 25, 2015

First Posted

July 1, 2015

Study Start

November 1, 2014

Primary Completion (Estimated)

October 1, 2030

Study Completion (Estimated)

October 1, 2036

Last Updated

February 18, 2025

Record last verified: 2025-02

Locations

US(1)